TipRanks
Advertisement
Advertisement
Beacon Therapeutics Reports Positive Pivotal Trial Results in XLRP Gene Therapy
PremiumPrivate CompaniesBeacon Therapeutics Reports Positive Pivotal Trial Results in XLRP Gene Therapy
11d ago
Beacon Therapeutics CEO to Join Forum Discussion on Retinal Gene Therapy Advances
Premium
Private Companies
Beacon Therapeutics CEO to Join Forum Discussion on Retinal Gene Therapy Advances
15d ago
Beacon Therapeutics Executive to Join Advanced Therapies Europe 2026 Panel on Early-Phase Data
Premium
Private Companies
Beacon Therapeutics Executive to Join Advanced Therapies Europe 2026 Panel on Early-Phase Data
1M ago
Beacon Therapeutics Highlights Phase 2 XLRP Gene Therapy Data at ASRS 2026
PremiumPrivate CompaniesBeacon Therapeutics Highlights Phase 2 XLRP Gene Therapy Data at ASRS 2026
3M ago
Beacon Therapeutics Deepens Partner Outreach as Pivotal VISTA Trial Nears Key Data Milestone
Premium
Private Companies
Beacon Therapeutics Deepens Partner Outreach as Pivotal VISTA Trial Nears Key Data Milestone
3M ago
Beacon Therapeutics – Weekly Recap
Premium
Private Companies
Beacon Therapeutics – Weekly Recap
3M ago
Beacon Therapeutics Highlights Progress in Gene Therapy Program for X-Linked Retinitis Pigmentosa
PremiumPrivate CompaniesBeacon Therapeutics Highlights Progress in Gene Therapy Program for X-Linked Retinitis Pigmentosa
4M ago
Beacon Therapeutics – Weekly Recap
Premium
Private Companies
Beacon Therapeutics – Weekly Recap
4M ago
Beacon Therapeutics CMO Participation Underscores Focus on Inherited Retinal Disease Therapies
Premium
Private Companies
Beacon Therapeutics CMO Participation Underscores Focus on Inherited Retinal Disease Therapies
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―